← All stocks

Apimeds Pharmaceuticals US, Inc.

APUS Net buying

CIK 0001894525 #5370 in the set updated 21 Sep 2026

Bought (120 mo)

$2.11M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$2.11M

+$2.11M against sales at will

By person

4 insiders · 7 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Inscobee Inc. entity

10% owner

$2.00M (1)

—

+$2.00M

6,416,365

42.52%

$11.93M

+14.2%

Koo Jakap

Director

$56.72K (1)

—

+$56.72K

643,885

4.27%

$1.20M

+4.6%

Kim Christopher

Chairman and CMO

$50.36K (2)

—

+$50.36K

277,500

1.84%

$516.15K

—

Emerson Erik C.

Chief Executive Officer

—

750,000

4.97%

$1.40M

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 22

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,297,133

History held since 14 May 2025